Domingo Ernesto Uceda

315 posts

Domingo Ernesto Uceda banner
Domingo Ernesto Uceda

Domingo Ernesto Uceda

@DomUceda

Husband. Father. Vascular Surgery trainee. American.

Philadelphia, PA Katılım Mart 2012
631 Takip Edilen399 Takipçiler
Domingo Ernesto Uceda retweetledi
Dr. Glaucomflecken
Dr. Glaucomflecken@DGlaucomflecken·
@mass_marion So PBMs on the hospital supply side. Neat.
English
4
6
52
13.8K
Domingo Ernesto Uceda retweetledi
Bo Wang
Bo Wang@BoWang87·
Few people realize how fast AI is already revolutionizing surgery! Medivis's SurgicalAR platform for assisting neurosurgeons during surgery just received FDA clearance in Dec 2025. We keep debating whether AI will replace doctors. Meanwhile surgeons are literally seeing through patients with AR navigation in real-time. The right question was never replacement. It was always: what does a surgeon become when they have superhuman perception? We will share a lot more projects in AI & surgery soon from @UHN ! Stay tuned
English
13
49
274
41.1K
Domingo Ernesto Uceda retweetledi
Ron Barbosa MD FACS
Ron Barbosa MD FACS@rbarbosa91·
@mahesh_shenai Unfortunately, you can’t just keep neurosurgeons on the shelf in a freeze-dried state and just rehydrate them when there’s an emergency, and then freeze-dry them again afterwards so you don’t have to feed them any elective work. As others have said, there’s no real answer.
English
2
4
93
28.4K
Domingo Ernesto Uceda retweetledi
Endospan
Endospan@EndospanLtd·
We are proud to announce a major milestone in our mission to deliver a minimally invasive alternative for aortic care. The FDA has approved the NEXUS Aortic Arch Stent Graft for treatment of the ascending aorta and arch in chronic dissection patients who are at high risk for open surgical repair. You can read the full press release and learn more here: tinyurl.com/4dksye7k #NEXUSaorta #totalarch #aorticdissection #aorticarchrepair #aortaEd Essential Prescribing Information: tinyurl.com/594ntx44
Endospan tweet media
English
0
1
4
2.8K
Domingo Ernesto Uceda retweetledi
PennSurgery
PennSurgery@pennsurgery·
This morning we held our 8th Resident Research Presentations in place of our weekly M&M. We kicked things off with Karole T. Collier, MD, PGY-5 General Surgery Resident, mentored by Rachel Kelz, MD. Our second presentation featured Domingo E. Uceda, MD, Integrated Vascular Surgery Resident. Great work by both highlighting innovation, research, and dedication to advancing patient care!
PennSurgery tweet mediaPennSurgery tweet media
English
0
1
2
887
Domingo Ernesto Uceda retweetledi
JAMA
JAMA@JAMA_current·
#AI scribe adoption across 5 academic centers was associated with modest reductions in EHR and documentation time, plus a slight increase in weekly visit volume, especially for primary care and female clinicians. ja.ma/3NzDzUo
JAMA tweet media
English
3
23
72
23.8K
Domingo Ernesto Uceda retweetledi
Aaron Burnett
Aaron Burnett@aaronburnett·
Someone just caught Artemis from their flight. Cool view of little piece of history!
English
497
11.1K
86.5K
3M
Domingo Ernesto Uceda retweetledi
Megan Tracci
Megan Tracci@MeganTracci·
@rowe_vincent @SCVS1969 @VascularSVS When data on 1.7 million operations shows surgeons are doing longer operations on sicker, more complex patients - yet facing a 2.5% reduction in wRVU payment based on flawed assumptions about efficiency... Wonder why our surgeons are burning out at record rates?
Megan Tracci tweet mediaMegan Tracci tweet media
English
0
9
30
1.3K
Domingo Ernesto Uceda
Domingo Ernesto Uceda@DomUceda·
Vascular surgery is challenging. Joy in the work is why we choose it. Important address by Dr. Rowe at #SCVS2026
Domingo Ernesto Uceda tweet media
English
1
0
11
692
Domingo Ernesto Uceda retweetledi
NEJM
NEJM@NEJM·
Presented at #ACC26: In patients with pulmonary embolism, ultrasound-facilitated, catheter-directed fibrinolysis led to a lower risk of a composite of major adverse outcomes than anticoagulation alone. Full HI-PEITHO trial results: nejm.org/doi/full/10.10… Editorial: Advanced Therapy for Intermediate-Risk Pulmonary Embolism nejm.org/doi/full/10.10… @ACCinTouch
NEJM tweet media
English
1
80
205
44.2K
Domingo Ernesto Uceda retweetledi
Google
Google@Google·
Your headphones just became a personal translator in 70+ languages. 🎧✨ Google Translate’s “Live translate” with headphones is officially on iOS. We're also expanding this capability to more countries around the world for both @Android and iOS users. To try it, open the Translate app, tap “Live translate” and connect your headphones.
English
438
2.1K
13.2K
7.9M
Domingo Ernesto Uceda retweetledi
Grace Wang
Grace Wang@Grace_WangMD·
I hope you enjoy reading this issue as much as I enjoyed helping to put it together. Thanks to the authors who contributed their expertise and opinions on complex aortic repair in the March 2026 edition of Endovascular Today. evtoday.com/articles/2026-…
English
0
1
6
237
Domingo Ernesto Uceda retweetledi
Anthony DiGiorgio, DO, MHA
Anthony DiGiorgio, DO, MHA@DrDiGiorgio·
When a patient is in the hospital, doctors used to use paper notes to communicate with one another. In the EHR era, the note stopped being a clinical communication tool and became a billing and compliance artifact. The results have been a disaster. One JAMA study found notes got 60.1% longer from 2009 to 2018, while redundancy rose 22%. ONC has explicitly acknowledged that clinicians use templates to stuff notes with unnecessary information into the chart to meet billing requirements, creating note bloat. The clinical note was no longer a method of communication. It was a billing document. So hospitals layered secure chat on top just to communicate the actual plan of care. And even that workaround is not working. A 2024 JAMA study found more secure messaging was associated with more time on the phone, not less. Doctors needed to call to clarify the now constant message stream. Another study found higher messaging volume was associated with higher odds of errors. More messages means a higher cognitive load with most of the information being low-importance. This increased cognitive load leads to more errors. We took what should have been efficiency improving technology, a computerized chart, and so over-regulated it and misaligned incentives that it has led to harmful downstream effects. Now, please don't do this with AI...
English
72
136
627
40.6K
Domingo Ernesto Uceda retweetledi
Stefano Garzon, MD
Stefano Garzon, MD@stefano_garzon·
🧵 ROLLING STONE Registry (Cerrato et al, JACC Intv 2026) 1/21 ROLLING STONE is the kind of registry the interventional community needs. Large, prospective, core-lab adjudicated, with an independent events committee. But even such good data deserve good scrutiny. Let's walk through what the numbers tell us and what the methods can and cannot do.
Stefano Garzon, MD tweet media
English
2
8
36
6.7K
Domingo Ernesto Uceda retweetledi
Dr. Marty Makary
Dr. Marty Makary@DrMakaryFDA·
FDA’s new guidance on Bayesian statistics is creating a lot of buzz! “The importance of the guidance cannot be overstated. It underscores FDA’s commitment to modernizing clinical research and promoting the use of bayesian methods in clinical trials.” jamanetwork.com/journals/jama/…
English
82
60
305
54.2K
Domingo Ernesto Uceda retweetledi
EJVES
EJVES@EJVES_ESVS·
🌟 AUTHOR SPOTLIGHT: Dr. Trisha Roy 🌟 Visualizing the invisible: How drugs interact with complex plaque. In a recent #EJVESForum study, @TrishaRoyMD and her team at Houston Methodist and Weill Cornell Medical College developed a groundbreaking Scanning Electron Microscopy (SEM) approach to evaluate how paclitaxel is deposited from Drug-Coated Balloons (DCBs). 🔍 MEET THE AUTHOR: Affiliations: Houston Methodist Hospital & Weill Cornell Medical College, Houston, TX, USA 🇺🇸. Expertise: A pioneer in using advanced imaging and human cadaveric models to study peripheral artery disease (PAD) and endovascular outcomes. The Vision: Moving beyond animal models to understand how vessel preparation—like cutting balloons—changes drug transfer in real human calcified lesions. 💡 WHY THIS RESEARCH MATTERS: Current DCB data often comes from healthy animal vessels, which don't mimic the "rock-hard" calcium surgeons face daily. Dr. Roy’s work uses a human cadaveric PAD model to show that vessel preparation significantly impacts how much drug actually stays on the vessel wall. 🚀 THE CLINICAL IMPACT: By using SEM to map drug distribution at a microscopic level, we can finally see why some lesions respond to DCBs while others don't. It’s about optimizing every millimeter of the artery for the best long-term patency. Read the full study and join the discussion 👇 ejvesvascularforum.com/article/S2666-… #EJVESforum #VascTwitter #VascularSurgery #PAD #DCB #ScanningElectronMicroscopy #MedEd #ESVScommunity #VasculaRes #SurgicalInnovation #MeetTheAuthor @vascularis @bazinger_z @FLareyre @MariaKatsarou14 @NicLeoneMD @ESVSmembership @EVST_ESVS @WeillCornell @HMethodistCV @HMethodistMD @MethodistHosp
EJVES tweet mediaEJVES tweet media
English
0
3
12
3.5K